CLOs on the Move

Homecare Homebase

www.hchb.com

 
Homecare Homebase develops mobile software solutions for home health and hospice agencies, using real-time data to reduce paperwork, streamline agency processes and boost productivity for expert patient care.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.hchb.com
  • 6688 North Central Expressway Suite 800
    Dallas, TX USA 75206
  • Phone: 214.239.6700

Executives

Name Title Contact Details
Hannah Pearson
Chief Revenue Officer (CRO) Profile

Similar Companies

Lasering USA

Lasering USA is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.

Health Robotics Canada

Health Robotics Canada is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

The CDM Group

The CDM Group is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. The CDM Group is based in New York, NY. You can find more information on The CDM Group at www.thecdmgroup.com

Roger Green and Associates

Roger Green and Associates is a New Hope, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Berg LLC

BERG is a Boston-based biopharma company focused on taking a bold “back to biology” approach to therapeutic discovery using its unique AI-based Interrogative Biology® platform. This platform combines patient biology and AI-based analytics to engage the differences between healthy and disease environments. The patient’s own biology drives the platform’s results and guides us in the discovery and development of drugs, diagnostics and healthcare applications. Our platform utilizes patient population health data to bring actionable Patient IntelligenceTM to precision medicine applications. For patients this means faster discovery and development of treatments, more effective precision treatments for individuals as well as a reduction in costs to our healthcare systems. BERG has a robust product portfolio in oncology, endocrinology and neurology with mature assets in oncology entering mid and late stage trials. BERG is committed to improving the lives of patients through precision medicine made possible by our innovative platforms.